SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Filings re: Registrant of ‘8-K’ Filing 1415889-17-431


        

236  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
10/13/22  Fluoropharma Medical, Inc.        15-15D     10/13/22    1:13K                                    SEC Filing Solut… LLC/FA 
 6/23/22 Fluoropharma Medical, Inc.        8-K:5,9     6/22/22   11:1.1M                                   SEC Filing Solut… LLC/FA 
 5/15/17  Fluoropharma Medical, Inc.        NT 10-Q     3/31/17    1:19K                                    SEC Connect              
 3/31/17  Fluoropharma Medical, Inc.        10-K       12/31/16   64:4.3M                                   Blueprint/FA             
 3/20/17  Fluoropharma Medical, Inc.        CT ORDER    3/17/17    1:11K                                    SEC #7                   
 3/15/17  Fluoropharma Medical, Inc.        8-K:1,2,3,9 1/24/17    8:650K                                   SEC Connect              
  3/2/17  Fluoropharma Medical, Inc.        8-K:1,3,5,9 2/24/17    2:51K                                    Blueprint/FA             
12/29/16  Fluoropharma Medical, Inc.        8-K:2,5,9  12/22/16    2:61K                                    Blueprint/FA             
12/15/16  Fluoropharma Medical, Inc.        10-Q/A      6/30/16    3:98K                                    Blueprint/FA             
 12/5/16  Fluoropharma Medical, Inc.        8-K:1,3,9  11/29/16    2:53K                                    Blueprint/FA             
11/14/16  Fluoropharma Medical, Inc.        10-Q        9/30/16   48:2.5M                                   Blueprint/FA             
 11/4/16  Fluoropharma Medical, Inc.        8-K:1,2,3,910/31/16    1:46K                                    Blueprint/FA             
 9/30/16  Fluoropharma Medical, Inc.        8-K:2       9/27/16    2:62K                                    Blueprint/FA             
 8/18/16  Fluoropharma Medical, Inc.        8-K:1,5,9   8/15/16    2:298K                                   SEC Connect              
 8/15/16  Fluoropharma Medical, Inc.        10-Q        6/30/16   52:2.6M                                   SEC Connect              
 7/27/16  Fluoropharma Medical, Inc.        8-K:1,9     7/22/16    3:67K                                    SEC Connect              
 7/27/16  Fluoropharma Medical, Inc.        CT ORDER               1:11K                                    SEC #7                   
 7/20/16  Fluoropharma Medical, Inc.        DEF 14A     7/20/16    1:188K                                   SEC Connect              
 7/18/16  Fluoropharma Medical, Inc.        8-K:7,9     7/18/16    2:3.2M                                   SEC Connect              
  7/1/16  Fluoropharma Medical, Inc.        PRE 14A      7/1/16    1:210K                                   SEC Connect              
____________
 ‡  A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm
Five-thirty emoji
ET
.  The legal “Filed As Of” date may be the next, or another, day.
 ¹  Filing/Form Types: 
Type emoji
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  10-K    Annual Report — Form 10-K.
  10-Q    Quarterly Report — Form 10-Q.
  15-15D    Notice of a Suspension of Duty to File Reports — Form 15.
  CT ORDER    SEC Confidential Treatment Order.
  DEF 14A    Definitive Proxy Statement — Schedule 14A.
  NT 10-Q    Notice of a Late Filing of a Form 10-Q Quarterly Report — Form 12b-25.
  PRE 14A    Preliminary Proxy Statement — Schedule 14A.
  /A  Amendment to, or Amended version of, a previous Filing of this Type.
 
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 9:41:04.8pm ET